期刊文献+

尿毒症血液透析患者动脉粥样硬化的研究

The study of atherosclerotic in uremia patients treated with hemodialysis.
原文传递
导出
摘要 目的探讨尿毒症患者维持性血液透析(MHD)动脉粥样硬化及其危险因素的研究。方法选择在血透室治疗的 MHD 患者30例,健康体检者21名为对照组,进行颈动脉高频彩色多普勒超声检查,测量血清 C 反应蛋白(CRP),肿瘤坏死因子(TNF)a,血糖(GIU),白蛋白(ALB)浓度及钙磷乘积,对病例组及对照组诸指标进行分析。结果病例组与对照组比较,颈动脉内膜-中层厚度(IMT),CRP,TNFa 钙磷乘积(Ca×P)均明显增高,ALB 则明显降低,GIU 两者差异无显著性。结论尿毒症血液透析患者颈动脉硬化与炎症的营养不良状态具有相关性,后者是前者的危险因素。 Objective To evaluate the atherosclerotic and its risk factors in uremia patients with treated with hemodialy- sis.Methods the 30 cases of MHD patients and 21 health controls were chosen,the colour doppler's examination in neck atreria,serum CRP,,TNF-α,serum glucose,albumin and the calcium times phorphorus were analysed.Re- sults the IMT index,the level of CRP,TNF-αand Ca * P were higher in patients group than those of in control group,the level of albumin in patients group was decreased significantly and the level of Glu was not difference.Con- clusion the arteriosclerosis in uremia patients is related to the infections and nutrition status,the later is the risk factor of the former.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2006年第S2期10-11,共2页 Chinese Journal of Practical Internal Medicine
基金 汕头市重点科技计划项目(0682)
关键词 尿毒症 血液透析 Uremia Hemodialysis
  • 相关文献

参考文献5

  • 1杨照勇,荣海钦.C反应蛋白与代谢综合征[J].国外医学(内分泌学分册),2004,24(3):173-175. 被引量:58
  • 2Ridker P M,Cushman M,Stampfer M J,et al.Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men[].The New England Journal of Medicine.1997
  • 3Kaysen G A.C-reactive protein: A story half told[].Seminars in Dialysis.2000
  • 4Qureshi A R,Alvestrand A,Danielsson A,et al.Factors predicting malnutrition in hemodialysis patients: a cross-sectional study[].Kidney International.1998
  • 5Nieto F J,Adam E,Sorlie P,et al.Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis[].Circulation.1996

二级参考文献17

  • 1Weyer C, Yudkin JS, Stehouwer CD, et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis,2002,161:233-242.
  • 2Daniel G, Hackam MD, Sonia S. Emerging risk factors for atherosclerotic vascular disease. JAMA, 2003,290: 932-939.
  • 3Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 2002,105:1890-1896.
  • 4Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Eng J Med,2002,347,1557-1564.
  • 5Keller KB, Lemberg L. Obesity and the metabolic syndrome. Am J Crit Care, 2003,12:167-170.
  • 6Mortensen RF. C-reactive protein, inflammation, and innate immunity.Immunol Res, 2001,24:163-176.
  • 7Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation,2000, 102:2165-2167.
  • 8Venugopal SK, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein decrease eNOS expression and bioactivity in human aortic endothelial cells. Circulation, 2002,106:1439-1441.
  • 9Festa AD, Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistanee syndrome. Circulation, 2000,102:42-47.
  • 10Leinonen E, Hurt-Camejo E, Wiklund O, et al. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis, 2003,166: 384-394.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部